ABBOTT LABORATORIES business relationships
Companies named in ABBOTT LABORATORIES’s 10-K filed 2026-02-20, and public companies whose annual reports name ABBOTT LABORATORIES. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 6.7 / 10
- AI naming
- 100 / 100 Top 1% in its category
- Agent readiness
- 35 / 100
- AI adoption
- 0 / 100
Named in ABBOTT LABORATORIES’s annual report 0
No company named in this filing matched a company in the map.
Companies whose annual reports name ABBOTT LABORATORIES 22
“Confidential Settlement and Patent License Agreement, dated December 20, 2024, between Abbott Diabetes Care Inc. and DexCom, Inc.” SEC filing
“We collaborate with leading medical device companies and academic institutions for the development and distribution of our surgical planning software, services, and products, such as Zimmer Biomet and DePuy Synthes, as well as Enovis, Integra, Lima, Mathys, Medtronic, Abbott and Corin.” SEC filing
“...ment with Ortho under which we continue as exclusive supplier of antigens to Ortho, while retaining the right to supply antigens to third parties (including Abbott Laboratories, Siemens and OraSure Technologies) and to develop products independently, subject to customary intellectual property terms.” SEC filing
“There can be no assurance that our collaborations with Dexcom and Abbott will be successful or that we will not experience delays, business disputes, or other unanticipated challenges.” SEC filing
“We rely on several large customers for a significant percentage of our revenue, including Abbott Laboratories, certain distributors, and certain other customers.” SEC filing
“Amendment No. 11 to Supplier Partnering Agreement between Abbott and the company (incorporated by reference to our Form 8-K/A filed February 13, 2025).” SEC filing
“Collaborative Development and License Agreement between the Company and Abbott Laboratories, dated November 27, 2006; as amended by a First Amendment to Collaborative Development and License Agreement dated January 27, 2009 and a Second Amendment to Collaborative Development and License Agreement da...” SEC filing
“Our pharmaceutical and biotechnology customers include companies and research laboratories such as Abbott, Amgen, AstraZeneca, Bayer, Glaxo Smith Kline, Johnson & Johnson, Merck, Novartis, Pfizer and Regeneron.” SEC filing
“All obligations under the prior license agreement have been completed except that Lipocine will owe Abbott a perpetual 1 % royalty” SEC filing
“During 2025, three of our customers, Abbott Laboratories, Boston Scientific and Medtronic were each in excess of 10% of total sales and collectively accounted for 49% of our total sales.” SEC filing
“On July 31, 2024, we entered into a global integration, supply, and distribution agreement with Abbott (the "Abbott Partnership") to expand access to our AID and Smart MDI systems.” SEC filing
“In addition to our Simplera and Simplera Sync, we have introduced an additional complementary CGM option through our global partnership with Abbott.” SEC filing
“Abbott supplies us with Instinct, an alternative CGM sensor based on Abbott's most advanced single-analyte CGM technology, and will be the exclusive supplier of third-party CGMs for certain of our AID and Smart MDI systems.” SEC filing
“...marketing initiatives including via the Bionic Universe, leveraging our partnerships with global leaders in CGM technology like Dexcom and Abbott, growing our internal customer support team, continuing to enhance our product offerings and pursuing a multi-channel coverage and reimbursement strategy.” SEC filing
“We have also partnered with Dexcom and Abbott-global leaders in popular and easy to use iCGM technology-to integrate the iLet with the Dexcom G6 and G7 iCGMs and with Abbott's FreeStyle Libre 3 Plus Continuous Glucose Monitor (CGM) sensor.” SEC filing
“Additionally, a reseller agreement with Abbott Rapid Diagnostics UK & Ireland supports the distribution of Afinion™ 2 devices” SEC filing
“all reagents also available on other immunoassay platforms offered by major companies such as Abbott, Beckman, Siemens, and ThermoFisher” SEC filing
“have established reagent contracts with Roche and Abbott that guarantee pricing for all immunoassay and chemistry markers currently used” SEC filing
“Under the Collaboration Agreement, Abbott will share insights from recent” SEC filing
“provided by a few mid-sized to large diagnostic companies (e.g., Roche Diagnostics, Abbott Laboratories, Siemens Healthineers AG, DiaSorin” SEC filing
“Health/beauty customers include GlaxoSmithKline, Bayer, Johnson & Johnson, Abbott, Novartis, L'Oréal S.A., Procter & Gamble and Colgate-Palmolive.” SEC filing
“Abbott has established growth platforms for a range of investment management entrepreneurs, businesses, and client-types, currently serving” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.